Solara Active Pharma Sciences Ltd

NSE
SOLARA •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Solara Active Pharma Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High today
46.1
TTM PE Ratio
Negative PE TTM
-5.7
Price to Book Ratio
Low in industry
1.2
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI Overbought
73
MFI
MFI strongly Overbought
84.7

Solara Active Pharma Sciences Ltd Key Financials

*All values are in ₹ Cr.

Solara Active Pharma Sciences Ltd shareholding Pattern

Promoter
30.5%
Foreign Institutions
16.6%
Mutual Funds
1.7%
Domestic Institutions
1.8%
Public
51.1%

Solara Active Pharma Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
467.00
10Day EMA
443.40
12Day EMA
437.40
20Day EMA
423.10
26Day EMA
416.40
50Day EMA
398.70
100Day EMA
382.00
200Day EMA
383.30
Delivery & Volume
Resistance & Support
492.30
Pivot
Resistance
First Resistance
502.70
Second Resistance
516.90
Third Resistance
527.30
Support
First Support
478.10
Second support
467.70
Third Support
453.50
Relative Strength Index
72.95
Money Flow Index
84.72
MACD
21.05
MACD Signal
10.06
Average True Range
24.86
Average Directional Index
25.72
Rate of Change (21)
22.62
Rate of Change (125)
32.74

Solara Active Pharma Sciences Ltd Company background

Founded in: 2017
Managing director: Jitesh Devendra
Solara Active Pharma Sciences Ltd is a Public Limited Company incorporated in February 23, 2017 under the provisions of Companies Act, 2013 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has six APIs manufacturing plants located in Ambernath, Mangalore, Mysore, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,000 kilo litres and two RD Centres in Chennai and Bangalore. The business is spread across 75 countries globally with extensive operations in key markets of North America, Europe, Japan, South Korea, the Middle East and North Africa.The Company offer rich basket of niche highvalue products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, antimalarias, antiinfective, neuromuscular insomnia and antipsychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units in Bengaluru and Chennai equipped with stateoftheart facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, antimalarias, beta blockers,muscle relaxants, novel oral anticoagulants, antiinfective and other niche segments.The Companys manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA) European Directorate for the Quality of Medicines (EDQM) Korea Food Drug Administration (KFDA) South Korea Euro Zone Good Manufacturing Practice (EUGMP) Danish, World Health Organization (WHO) Geneva Medicines and Healthcare products RegulatoryAgency (MHRA) Federal Commission for the Protection against Sanitary Risk (Cofepris) Mexico Therapeutic Goods Administration (TGA) Australia Pharmaceuticals and Medical Devices Agency (PMDA) Japan.During the year, the Companys wholly owned subsidiary Strides Chemicals Private Limited (Strides Chemicals) was amalgamated with the Company. The Honourable National Company Law Tribunal, Mumbai Bench, approved the Scheme of Amalgamation of Strides Chemicals with Company on December 20, 2019. Accordingly, the Company has fixed effective date for the Scheme is February 01, 2020. The appointed date for scheme is September 01, 2018. The Company has completed filing of necessary documents for giving effect to the Scheme. Consequent to amalgamation, the entire equity shares held by Company in Strides Chemicals stands cancelled.The Board of Directors of Company at its meeting held on April 09, 2021 have approved Scheme of Amalgamation for merger of Aurore Life Science Private Limited, Empyrean Lifesciences Private Limited and Hydra Active Pharma Sciences Private Limited (Transferor Companies) into the Company (Transferee Company) in terms of Section 230 to 232 of the Companies Act, 2013. The Scheme is subject to necessary statutory and regulatory approvals including the approvals of National Company Law Tribunal, the shareholders and creditors of each of the companies. The Appointed Date for the said Scheme of Amalgamation is April 01, 2021 or such other date as may be agreed between the Transferor Company and Transferee Company and approved by National Company Law Tribunal.The Companys new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam 531011, Andhra Pradesh, has commenced commercial production in 2021.The Board at its meeting held on February 3, 2021 has approved to acquire 4,87,000 additional share capital in Sequent Penems Private Limited, subsidiary company of Solara. Subsequent to year end, the said transaction is completed and Sequent Penems Private Limited is wholly owned subsidiary of Company with effect from April 27, 2021.The achievements received by the Company in FY 202021 were as follows: The Ambernath facility received Certificate of Merit from National Safety Council, Maharashtra for Lowest Average Accident Frequency Rate. They improved EcoVadis Score from 31 to 47 and was awarded a bronze medal in recognition of Sustainability achievement. The Mangalore site of company was certified for ISO 14001 and ISO 45001. Besides, they conducted a Red Tag Event to identify unsafe conditions and acts to make workplace injury nd incident free. All employees and contractors actively participated in the event..
Read More

Solara Active Pharma Sciences Ltd FAQs

Solara Active Pharma Sciences Ltd shares are currently priced at 488.5 on NSE and 488.6 on BSE as of 2/22/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Solara Active Pharma Sciences Ltd [SOLARA] share was 31.81. The Solara Active Pharma Sciences Ltd [SOLARA] share hit a 1-year low of Rs. 286 and a 1-year high of Rs. 506.5.

The market cap of Solara Active Pharma Sciences Ltd is Rs. 1758.42 Cr. as of 2/22/2024 12:00:00 AM.

The PE ratios of Solara Active Pharma Sciences Ltd is 0 as of 2/22/2024 12:00:00 AM.

The PB ratios of Solara Active Pharma Sciences Ltd is 1.19 as of 2/22/2024 12:00:00 AM

The Mutual Fund Shareholding was 1.71% at the end of 2/22/2024 12:00:00 AM.

You can easily buy Solara Active Pharma Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage